Position in ALNY
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$25,146,120
+$18,342,727 QoQ
Shares Held
76,000
+344.2% QoQ
Ownership
0.057%
of shares outstanding
% of Portfolio
4.12%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2021
4 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Prosight Management, LP holds $368,598,367 across 29 Biotechnology names. ALNY ranks #6 (6.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NKTR |
Nektar Therapeutics
|
735,000 | $52,883,250 | |
| 2 | JANX |
Janux Therapeutics, Inc.
|
3,550,000 | $49,345,000 | |
| 3 | LKFT |
Lakefront Biotherapeutics NV
|
1,550,000 | $46,500,000 | |
| 4 | STTK |
Shattuck Labs, Inc.
|
5,004,439 | $32,178,542 | |
| 5 | KURA |
Kura Oncology, Inc.
|
3,356,700 | $27,289,971 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
76,000 | $25,146,120 | |
| 7 | MGTX |
MeiraGTx Holdings plc
|
2,629,971 | $22,775,548 | |
| 8 | SNDX |
Syndax Pharmaceuticals Inc
|
770,000 | $17,987,200 |
All Filings in ALNY
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $25,146,120 | 76,000 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $6,803,393 | 17,109 | Shares | Sole | 2026-02-13 | |
| 2022-03-31 | $3,707,336 | 22,704 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $5,410,789 | 31,907 | Shares | Sole | 2022-02-14 | |
| No filing history on record for this holder in this stock. | ||||||